Medicure Statistics
Want to see TSE:MPH full AI Analyst Report?
Medicure (MPH) Stock Statistics & Valuation Metrics
Total Valuation
Medicure has a market cap or net worth of CAD 39.66M. The enterprise value is CAD 12.33M.
- Market Cap
- CAD 39.66M
- Enterprise Value
- CAD 12.33M
Share Statistics
Medicure has 10,436,313 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 10,436,313
- Owned by Insiders
- 24.94%
- Owned by Institutions
- ―
Financial Efficiency
Medicure’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is -49.91%.
- Return on Equity (ROE)
- -0.55
- Return on Assets (ROA)
- -0.28
- Return on Invested Capital (ROIC)
- -49.91%
- Return on Capital Employed (ROCE)
- -0.52
- Revenue Per Employee
- 1.15M
- Profits Per Employee
- -283.88K
- Employee Count
- 25
- Asset Turnover
- 1.16
- Inventory Turnover
- 5.98
Valuation Ratios
The current PE Ratio of Medicure is -5.18. Medicure’s PEG ratio is 0.05.
- PE Ratio
- -5.18
- PS Ratio
- 1.19
- PB Ratio
- 3.31
- Price to FCF
- -19.89
- Price to Operating Cash Flow
- -19.89
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, Medicure had revenue of 28.86M and earned -7.10M in profits. Earnings per share was -0.68.
- Revenue
- 28.86M
- Gross Profit
- 11.25M
- Operating Income
- -6.89M
- Pretax Income
- -6.89M
- Net Income
- -7.10M
- EBITDA
- -4.24M
- Earnings Per Share (EPS)
- -0.68
Cash Flow
In the last 12 months, operating cash flow was -1.93M and capital expenditures 0, giving a free cash flow of -1.93M billion.
- Operating Cash Flow
- -1.93M
- Free Cash Flow
- -1.93M
- Free Cash Flow per Share
- -0.18
Dividends & Yields
Medicure pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4.99%
- Earnings Yield
- -19.30%
Stock Price Statistics
- Beta
- 1.56
- 52-Week Price Change
- 210.08%
- 50-Day Moving Average
- 3.31
- 200-Day Moving Average
- 1.71
- Relative Strength Index (RSI)
- 57.06
- Average Volume (3m)
- 6,301
Important Dates
Medicure upcoming earnings date is Nov 25, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Nov 25, 2026
- Ex-Dividend Date
- ―
Financial Position
Medicure as a current ratio of 1.02, with Debt / Equity ratio of 6.90%
- Current Ratio
- 1.02
- Quick Ratio
- 0.77
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.69
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Medicure has paid 208.00K in taxes.
- Income Tax
- 208.00K
- Effective Tax Rate
- -0.03
Enterprise Valuation
Medicure EV to EBITDA ratio is -8.14, with an EV/FCF ratio of -19.46.
- EV to Sales
- 1.17
- EV to EBITDA
- -8.14
- EV to Free Cash Flow
- -19.46
- EV to Operating Cash Flow
- -19.46
Balance Sheet
Medicure has CAD 1.83M in cash and marketable securities with CAD 696.00K in debt, giving a net cash position of CAD 1.14M billion.
- Cash & Marketable Securities
- CAD 1.83M
- Total Debt
- CAD 696.00K
- Net Cash
- CAD 1.14M
- Net Cash Per Share
- CAD 0.11
- Tangible Book Value Per Share
- CAD 0.02
Margins
Gross margin is 38.00%, with operating margin of -22.62%, and net profit margin of -23.23%.
- Gross Margin
- 38.00%
- Operating Margin
- -22.62%
- Pretax Margin
- -22.70%
- Net Profit Margin
- -23.23%
- EBITDA Margin
- -14.36%
- EBIT Margin
- -22.68%
Analyst Forecast
The average price target for Medicure is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 38.25%
- EPS Growth Forecast
- -450.85%
Scores
- Smart Score
- ―
- AI Score
- 51
